These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8534608)

  • 1. Expression of endoglin in psoriatic involved and uninvolved skin.
    Rulo HF; Westphal JR; van de Kerkhof PC; de Waal RM; van Vlijmen IM; Ruiter DJ
    J Dermatol Sci; 1995 Sep; 10(2):103-9. PubMed ID: 8534608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of endoglin in the transition between psoriatic uninvolved and involved skin.
    van de Kerkhof PC; Rulo HF; van Pelt JP; van Vlijmen-Willems IM; De Jong EM
    Acta Derm Venereol; 1998 Jan; 78(1):19-21. PubMed ID: 9498020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An important role of tumor necrosis factor-alpha in the induction of adhesion molecules in psoriasis.
    Terajima S; Higaki M; Igarashi Y; Nogita T; Kawashima M
    Arch Dermatol Res; 1998 May; 290(5):246-52. PubMed ID: 9681675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunolocalization of adhesion molecules in psoriatic arthritis, psoriatic and normal skin.
    Veale D; Rogers S; Fitzgerald O
    Br J Dermatol; 1995 Jan; 132(1):32-8. PubMed ID: 7538776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial cell adhesion molecules in psoriasis.
    Lee ML; To T; Nicholson E; Schrieber L
    Australas J Dermatol; 1994; 35(2):65-70. PubMed ID: 7535517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inducibility and expression of microvascular endothelial adhesion molecules in lesional, perilesional, and uninvolved skin of psoriatic patients.
    Petzelbauer P; Pober JS; Keh A; Braverman IM
    J Invest Dermatol; 1994 Sep; 103(3):300-5. PubMed ID: 7521374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocyte adhesion to psoriatic dermal endothelium is mediated by a tissue-specific receptor/ligand interaction.
    Sackstein R; Falanga V; Streilein JW; Chin YH
    J Invest Dermatol; 1988 Nov; 91(5):423-8. PubMed ID: 3262692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adhesion molecule expression in psoriatic skin lesions and the influence of cyclosporin A.
    Horrocks C; Duncan JI; Oliver AM; Thomson AW
    Clin Exp Immunol; 1991 Apr; 84(1):157-62. PubMed ID: 2015706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UVB therapy decreases the adhesive interaction between peripheral blood mononuclear cells and dermal microvascular endothelium, and regulates the differential expression of CD54, VCAM-1, and E-selectin in psoriatic plaques.
    Cai JP; Harris K; Falanga V; Taylor JR; Chin YH
    Br J Dermatol; 1996 Jan; 134(1):7-16. PubMed ID: 8745879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E-selectin and vascular cell adhesion molecule-1 are critical for initial trafficking of helper-inducer/memory T cells in psoriatic plaques.
    Wakita H; Takigawa M
    Arch Dermatol; 1994 Apr; 130(4):457-63. PubMed ID: 7513146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization of elevated transforming growth factor-alpha in psoriatic epidermis.
    Turbitt ML; Akhurst RJ; White SI; MacKie RM
    J Invest Dermatol; 1990 Aug; 95(2):229-32. PubMed ID: 2380581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CD11b/CD18-integrin in the pathogenesis of psoriasis.
    van Pelt JP; Kuijpers SH; van de Kerkhof PC; de Jong EM
    J Dermatol Sci; 1998 Jan; 16(2):135-43. PubMed ID: 9459126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased synovial expression of transforming growth factor (TGF)-beta receptor endoglin and TGF-beta 1 in rheumatoid arthritis: possible interactions in the pathogenesis of the disease.
    Szekanecz Z; Haines GK; Harlow LA; Shah MR; Fong TW; Fu R; Lin SJ; Rayan G; Koch AE
    Clin Immunol Immunopathol; 1995 Aug; 76(2):187-94. PubMed ID: 7614737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiangiogenic therapy of established tumors in human skin/severe combined immunodeficiency mouse chimeras by anti-endoglin (CD105) monoclonal antibodies, and synergy between anti-endoglin antibody and cyclophosphamide.
    Takahashi N; Haba A; Matsuno F; Seon BK
    Cancer Res; 2001 Nov; 61(21):7846-54. PubMed ID: 11691802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of protein kinase C isoenzymes in normal and psoriatic adult human skin: reduced expression of protein kinase C-beta II in psoriasis.
    Fisher GJ; Tavakkol A; Leach K; Burns D; Basta P; Loomis C; Griffiths CE; Cooper KD; Reynolds NJ; Elder JT
    J Invest Dermatol; 1993 Oct; 101(4):553-9. PubMed ID: 8409523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. K16 expression in uninvolved psoriatic skin: a possible marker of pre-clinical psoriasis.
    Bhawan J; Bansal C; Whren K; Schwertschlag U;
    J Cutan Pathol; 2004 Aug; 31(7):471-6. PubMed ID: 15239676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocyte recognition of psoriatic endothelium: evidence for a tissue-specific receptor/ligand interaction.
    Chin YH; Falanga V; Streilein JW; Sackstein R
    J Invest Dermatol; 1989 Aug; 93(2 Suppl):82S-87S. PubMed ID: 2546996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoglin is overexpressed after arterial injury and is required for transforming growth factor-beta-induced inhibition of smooth muscle cell migration.
    Ma X; Labinaz M; Goldstein J; Miller H; Keon WJ; Letarte M; O'Brien E
    Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):2546-52. PubMed ID: 11116051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a psoriatic skin model produced with involved or uninvolved cells.
    Jean J; Leroy M; Duque-Fernandez A; Bernard G; Soucy J; Pouliot R
    J Tissue Eng Regen Med; 2015 Jul; 9(7):789-98. PubMed ID: 23281213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergy between anti-endoglin (CD105) monoclonal antibodies and TGF-beta in suppression of growth of human endothelial cells.
    She X; Matsuno F; Harada N; Tsai H; Seon BK
    Int J Cancer; 2004 Jan; 108(2):251-7. PubMed ID: 14639611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.